These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35285486)

  • 1. Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review.
    Vincken NLA; Balak DMW; Knulst AC; Welsing PMJ; van Laar JM
    Rheumatology (Oxford); 2022 Nov; 61(11):4232-4244. PubMed ID: 35285486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis.
    Hagenström K; Klinger T; Müller K; Willers C; Augustin M
    Br J Dermatol; 2024 Oct; 191(5):719-727. PubMed ID: 38924726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between smoking, psoriasis and psoriatic arthritis.
    Pezzolo E; Naldi L
    Expert Rev Clin Immunol; 2019 Jan; 15(1):41-48. PubMed ID: 30380949
    [No Abstract]   [Full Text] [Related]  

  • 6. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review.
    Wu PC; Huang IH; Wang CW; Tsai CC; Chung WH; Chen CB
    Am J Clin Dermatol; 2022 Nov; 23(6):775-799. PubMed ID: 36048409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis.
    Gregoire ARF; DeRuyter BK; Stratman EJ
    JAMA Dermatol; 2021 Feb; 157(2):198-201. PubMed ID: 33206132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence.
    Solmaz D; Ehlebracht A; Karsh J; Bakirci S; McGonagle D; Aydin SZ
    Clin Exp Rheumatol; 2020; 38(2):257-261. PubMed ID: 31287403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of systemic glucocorticoids in patients with psoriatic arthritis by Argentinian and other Latin-American rheumatologists.
    Aimo C; Cosentino VL; Sequeira G; Kerzberg E
    Rheumatol Int; 2019 Apr; 39(4):723-727. PubMed ID: 30830285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?
    Patrizi A; Venturi M; Scorzoni R; Pazzaglia M; Malavolta N; Bardazzi F
    G Ital Dermatol Venereol; 2014 Apr; 149(2):177-84. PubMed ID: 24819637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connecting the use of innovative treatments and glucocorticoids with the multidisciplinary evaluation through rule-based natural-language processing: a real-world study on patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Motta F; Morandini P; Maffia F; Vecellio M; Tonutti A; De Santis M; Costanzo A; Puggioni F; Savevski V; Selmi C
    Front Med (Lausanne); 2023; 10():1179240. PubMed ID: 37387783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M; Epstein D; Bojke L; Yang H; Craig D; Fonseca T; Myers L; Bruce I; Chalmers R; Bujkiewicz S; Lai M; Cooper N; Abrams K; Spiegelhalter D; Sutton A; Sculpher M; Woolacott N
    Health Technol Assess; 2011 Feb; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of smoking on prevalence of psoriasis and psoriatic arthritis.
    Gazel U; Ayan G; Solmaz D; Akar S; Aydin SZ
    Rheumatology (Oxford); 2020 Oct; 59(10):2695-2710. PubMed ID: 32500136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
    Pérez-Plaza A; Carretero G; Ferrandiz C; Vanaclocha F; Gómez-García FJ; Herrera-Ceballos E; De la Cueva-Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Torrado R; Carrascosa JM; Llamas-Velasco M; Rivera R; Jiménez-Puya R; García-Doval I; Descalzo MA;
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1021-1028. PubMed ID: 28252811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.